Skip to content

MRI as Noninvasive Innovative Approach in Detection and Monitoring of Malignant Oral Lesions in Fanconi Anemia Patients

MRI as Noninvasive Innovative Approach in Detection and Monitoring of Malignant Oral Lesions in Fanconi Anemia Patients

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07649031
Enrollment
80
Registered
2026-06-15
Start date
2026-06-23
Completion date
2030-05-31
Last updated
2026-07-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fanconi Anemia

Brief summary

This study being done to learn more about the use of medical Magnetic Resonance Imaging (mMRI) and dedicated dental MRI (ddMRI) as a non-invasive diagnosing tool when evaluating potential oral cancerous and precancerous lesions in Fanconi Anemia patients.

Interventions

DIAGNOSTIC_TESTMRIs

mMRI and ddMRI

Sponsors

University of Minnesota
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients with a diagnosis of Fanconi Anemia who are willing to participate and willing to have MRIs * Willing to provide informed consent

Exclusion criteria

* Patient without diagnosis of FA * Patients with FA who are under the age of 18 * Unable to tolerate any MRI due to claustrophobia * Any contraindication for the MRI * Unable to provide informed consent or comply with the study protocol

Design outcomes

Primary

MeasureTime frameDescription
sensitivity of mMRI and ddMRI in identifying dysplastic and malignant lesions in FA patients.Immediately after MRIProportion of positive lesions correctly diagnosed
specificity of mMRI and ddMRI in identifying dysplastic and malignant lesions in FA patients.Immediately after MRIProportion of negative lesions correctly diagnosed

Countries

United States

Contacts

CONTACTCarla Campbell, BS
camp2757@umn.edu612-625-6976
PRINCIPAL_INVESTIGATORRachel Uppgaard

University of Minnesota

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 3, 2026